 | | Vol. 14.04 – 3 February, 2022 |
| |
|
|
| The authors revealed that treatment with the human umbilical cord mesenchymal stromal cells significantly increased the proportion of activated primordial follicles in mouse ovaries both in vitro and in vivo.
[Stem Cell Reviews and Reports] |
|  |
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers reprogrammed CD34+-umbilical cord blood cells with the group O/D-negative blood type as a universal source for red blood cell generation.
[Stem Cell Research] |
|
|
|
| Scientists revealed that co-transplantation of umbilical cord mesenchymal stromal cells and autologous bone marrow mononuclear cells in patients with established type 1 diabetes was associated with reduced incidence of chronic diabetes complications.
[Cytotherapy] |
|
|
|
| Investigators loaded umbilical cord-derived MSCs with oncolytic adenoviruses expressing decorin or without foreign genes to treat breast cancer lung metastasis.
[Molecular Therapy Oncolytics] |
|
|
|
| Researchers showed that myeloid cells from cord blood could be activated to express T cell costimulatory markers, and also to produced Th1 promoting cytokines.
[Journal of Leukocyte Biology] |
|
|
|
| Scientists evaluated angiotensin-converting enzyme-2 (ACE2) expression, a disintegrin and metalloprotease domain 17 activity and serum ACE2 abundance in a cohort of matched villous placental and maternal serum samples from control pregnancies and pregnancies affected by symptomatic maternal SARS-CoV-2 infections in the 2nd trimester and 3rd trimester.
[American Journal of Pathology] |
|
|
|
| Researchers compared the erythroid potential of CD34+ hematopoietic stem and progenitor cells from 50 different umbilical cord blood donors and discovered that those donors gave rise to diverse frequencies of Glycophorin-A+ erythroid cells after in vitro differentiation, despite having similar frequencies of phenotypic hematopoietic stem cells initially.
[International Journal of Hematology] |
|  |
|
|
|
| The authors studied the proteome profiled of canine native and decellularized placenta to characterize the proteome related to maintenance of a microenvironment and structure suitable for tissue engineering applications.
[Journal of Proteomics] |
|
|
|
| | Leonhardt Ventures LLC announced that it has begun an active research program to combine its patent-pending klotho expression bioelectric stimulation technologies with newly acquired klotho expressing MSC technology.
[Leonhardt Ventures (Globe Newswire, Inc.)] |
|
|
|
|
| April 3 – 6, 2022
Warwick, England, United Kingdom |
|
|
|
|
|
| | Stanford University – Stanford, California, United States |
|
|
|
| | Penn State College of Medicine – Hershey, Pennsylvania, United States |
|
|
|
| Albert Einstein College of Medicine – Bronx, New York, United States |
|
|
|
| Harvard Medical School – Boston, Massachusetts, United States |
|
|
|
| Fox Chase Cancer Center, Temple University – Philadelphia, Pennsylvania, United States |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
